Louis H. Philipson
Affiliations: | University of Chicago, Chicago, IL |
Area:
Molecular Biology, Neuroscience Biology, General BiophysicsGoogle:
"Louis Philipson"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Haliyur R, Walker JT, Sanyoura M, et al. (2021) Integrated Analysis of the Pancreas and Islets Reveals Unexpected Findings in Human Male With Type 1 Diabetes. Journal of the Endocrine Society. 5: bvab162 |
| Herold KC, Reynolds J, Dziura J, et al. (2020) Exenatide ER in patients with Type 1 diabetes with and without residual insulin production. Diabetes, Obesity & Metabolism |
| Chung WK, Erion K, Florez JC, et al. (2020) Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 43: 1617-1635 |
| Chung WK, Erion K, Florez JC, et al. (2020) Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia |
| Pratley RE, Kanapka LG, Rickels MR, et al. (2020) Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. Jama. 323: 2397-2406 |
| Philipson LH. (2020) Harnessing heterogeneity in type 2 diabetes mellitus. Nature Reviews Endocrinology. 16: 79-80 |
| Harris A, Naylor RN, Sanyoura M, et al. (2020) 178-LB: Insights from the University of Chicago Monogenic Diabetes Registry on Diagnosis and Management of Monogenic Diabetes Diabetes. 69 |
| Zhang H, Maloney KA, Barbetti F, et al. (2020) 1453-P: Adaption of the ACMG/AMP Variant Interpretation Guidelines for GCK, HNF1A, HNF4A-MODY: Recommendations from the ClinGen Monogenic Diabetes Expert Panel Diabetes. 69 |
| Virostko J, Williams JM, Hilmes MA, et al. (2020) 1283-P: Multicenter Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Diabetes. 69 |
| Herold KC, Reynolds J, Dziura J, et al. (2020) Author response for "Exenatide ER in patients with Type 1 diabetes with and without residual insulin production" Diabetes, Obesity and Metabolism |